HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G third quarter forecast

This article was originally published in The Rose Sheet

Executive Summary

Double-digit earnings growth anticipated in fiscal third quarter (ending March 31), Chief Financial Officer Clayt Daley tells investors at Merrill Lynch Global Consumer Products Conference March 19-20. Sales expected to grow in high single digits after negative currency impact, Procter & Gamble adds. Year-end sales expected to be an improvement over their 2% decline in 2001, but will not yet reach P&G's long-term goal of 4%-6% growth...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010148

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel